Results 271 to 280 of about 301,296 (304)
Some of the next articles are maybe not open access.
Venous thromboembolism: An overview
Journal of Vascular Nursing, 2015Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common, lethal disorder that affects both hospitalized and nonhospitalized patients. PE and DVT are 2 clinical presentations of VTE and share the same predisposing factors. In most cases, PE is a consequence of DVT.
openaire +2 more sources
Venous thromboembolism in pregnancy
Current Treatment Options in Cardiovascular Medicine, 2009Low molecular weight heparins (LMWHs) appear to be as safe and effective as unfractionated heparin (UFH) for venous thromboembolic disease (VTED) treatment or prophylaxis during pregnancy. Experience with other parenteral anticoagulant drugs is very limited, and no alternative oral anticoagulants are available to date.
openaire +2 more sources
Epidemiology of Venous Thromboembolism
Seminars in Vascular Medicine, 2001The annual incidence of diagnosed venous thromboembolism (VTE) is 1 to 2 events per 1000 of the general population. VTE is very uncommon before age 20 years and, after 40 years of age, the incidence about doubles with each decade. Over half of episodes of VTE are deep vein thrombosis (DVT), and three quarters are first episodes. The incidence of VTE is
openaire +2 more sources
Epidemiology and prevention of venous thromboembolism
Nature Reviews Cardiology, 2022Neil Zakai, Pamela L. Lutsey
exaly
Prophylaxis of venous thromboembolism
American Heart Journal, 1980R J, Farrell, G J, Duffy
openaire +2 more sources
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
New England Journal of Medicine, 2020Rupert Bauersachs +2 more
exaly